Beijing Science Sun Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 43.40%

Beijing Science Sun Pharmaceutical Co Ltd (300485) has an Asset Resilience Ratio of 43.40% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥1.56 Billion

≈ $228.92 Million USD Cash + Short-term Investments

Total Assets

CN¥3.60 Billion

≈ $527.49 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2015–2024)

This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Check Beijing Science Sun Pharmaceutical Co Lt strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Beijing Science Sun Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 300485 market cap overview.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.56 Billion	43.4%
Total Liquid Assets	CN¥1.56 Billion	43.40%

Asset Resilience Insights

Very High Liquidity: Beijing Science Sun Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 43.40% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Beijing Science Sun Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Beijing Science Sun Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Alkem Laboratories Limited NSE:ALKEM	Drug Manufacturers - Specialty & Generic	31.91%
Beijing Tongrentang Co Ltd SHG:600085	Drug Manufacturers - Specialty & Generic	0.50%
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	28.06%
Jilin Aodong Pharmaceutical Group Co Ltd SHE:000623	Drug Manufacturers - Specialty & Generic	4.97%
Fujian Cosunter Pharmaceutical Co Ltd SHE:300436	Drug Manufacturers - Specialty & Generic	-2.56%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Medicine Co Ltd SHG:600216	Drug Manufacturers - Specialty & Generic	1.85%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%

Annual Asset Resilience Ratio for Beijing Science Sun Pharmaceutical Co Ltd (2015–2024)

The table below shows the annual Asset Resilience Ratio data for Beijing Science Sun Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	42.13%	CN¥1.50 Billion ≈ $218.96 Million	CN¥3.55 Billion ≈ $519.75 Million	+13.05pp
2023-12-31	29.08%	CN¥1.05 Billion ≈ $154.15 Million	CN¥3.62 Billion ≈ $530.04 Million	+3.99pp
2022-12-31	25.09%	CN¥895.39 Million ≈ $131.02 Million	CN¥3.57 Billion ≈ $522.27 Million	-8.27pp
2021-12-31	33.35%	CN¥1.13 Billion ≈ $166.03 Million	CN¥3.40 Billion ≈ $497.77 Million	+16.38pp
2020-12-31	16.97%	CN¥507.69 Million ≈ $74.29 Million	CN¥2.99 Billion ≈ $437.69 Million	-0.47pp
2019-12-31	17.44%	CN¥489.34 Million ≈ $71.61 Million	CN¥2.81 Billion ≈ $410.53 Million	+17.54pp
2018-12-31	-0.10%	CN¥-2.66 Million ≈ $-389.17K	CN¥2.76 Billion ≈ $403.96 Million	-22.88pp
2016-12-31	22.78%	CN¥505.00 Million ≈ $73.90 Million	CN¥2.22 Billion ≈ $324.36 Million	-6.78pp
2015-12-31	29.57%	CN¥575.00 Million ≈ $84.14 Million	CN¥1.94 Billion ≈ $284.59 Million	--

pp = percentage points

About Beijing Science Sun Pharmaceutical Co Ltd

SHE:300485 China Drug Manufacturers - Specialty & Generic

Market Cap

$644.21 Million

CN¥4.40 Billion CNY

Market Cap Rank

#10910 Global

#2971 in China

Share Price

CN¥9.14

Change (1 day)

+2.70%

52-Week Range

CN¥8.15 - CN¥15.18

All Time High

CN¥40.48